Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues

Oncology Reports

Volumn 10, Issue 4, 2003, Pages 791-796

  Yamamoto, Yutaka ^a,b   Yamashita, Jun Ichi ^c   Toi, Masakazu ^b   Muta, Mariko ^b   Nagai, Shigenori ^b   Hanai, Nobuo ^d   Furuya, Akiko ^d   Osawa, Yoshio ^e   Saji, Shigehira ^b   Ogawa, Michio ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOWA HAKKO KOGYO CO LTD   (Japan)

^e HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Aromatase; Breast cancer; Estrone sulfatase; Immunohistochemical analysis

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR; ESTRONE SULFATASE; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; SULFATASE; THYMIDINE PHOSPHORYLASE; TUMOR MARKER; VASCULOTROPIN A;

ADULT; ARTICLE; BREAST TUMOR; CANCER INVASION; ENZYMOLOGY; FEMALE; HUMAN; MENOPAUSE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; STROMA CELL; SURVIVAL RATE;

ADULT; AROMATASE; BREAST NEOPLASMS; CARCINOMA, DUCTAL; FEMALE; HUMANS; MENOPAUSE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, ESTROGEN; STROMAL CELLS; SULFATASES; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542577668     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.4.791     Document Type: Article

References (50)

1. Tekamal RR and Santen RJ: Local estrogen production. Is aromatase an oncogene? In: Endocrinology of Breast Cancer. Manni A (ed). Human Press, New Jersey, pp79-92, 1999.
2. Feigelson HS and Henderson BE: Estrogens and breast cancer. An epidemiological perspective. In: Endocrinology of Breast Cancer. Manni A (ed). Human Press, New Jersey, pp55-77, 1999.
3. Clarke R, Dickson RB and Lippman ME: Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions. Clit Rev Oncol Hematol 12: 1-23, 1992.
4. Lippman ME and Dickson RB: Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res 45: 383-440, 1989.
5. Henderson IC and Canellos GP: Cancer of the breast: the past decade (part 1). N Engl J Med 302: 17-30, 1980.
6. Samojlik E, Santen RJ and Wells SA: Adrenal suppression with aminoglutethimide. Differential effects of aminoglutethimide on plasma andtostenesione and estrogen levels. J Clin Endocrinol Metab 45: 480-487, 1977. (Pubitemid 8194484)
7. Edery M, Goussard S, Dehaennin L, Scholler R, Reiffsteck J and Drosdowsky MA: Endogenous oestradiol-17beta concentration in breast tumours determined by mass fragmentography and radioimmunoassay: relationship to receptor content. Eur J Cancer 17: 115-120, 1981. (Pubitemid 11167261)
8. Van Landeghem AAJ, Poortman J, Nabuurs M and Thijssen JHH: Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900-2906, 1985. (Pubitemid 15232767)
9. Mistry P, Griffiths K and Maynard PV: Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors. J Steroid Biochem 24: 1117-1125, 1986. (Pubitemid 16056645)
10. Samojlik E, Santen RJ and Worgul TJ: Plasma estrone sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma. Steroids 39: 497-507, 1982. (Pubitemid 13208988)
11. Vignon F, Terqui M, Westley B, Derocq D and Rochefort H: Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology 106: 1079-1086, 1980. (Pubitemid 10135755)
12. Santner SJ, Feil PD and Santen RJ: In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59: 29-33, 1984. (Pubitemid 14087520)
13. Pasqualini JR, Gelly C and Lecerf F: Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line(R-27) derived from MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 22: 1495-1501, 1986. (Pubitemid 17228769)
14. Lipton A, Santen RJ, Santner SJ, Harvey HA, Feil PD, White-Hershey D, Bartholomew MJ and Antle CE: Aromatase activity in primary and metastatic human breast cancer. Cancer 59: 779-782, 1987. (Pubitemid 17018756)
15. Perel E, Daniilescu D, Kharlip L, Blackstein M and Killinger DW: Steroid modulation of aromatase activity in human cultured breast carinoma cells. J Steroid Biochem 29: 393-399, 1988.
16. Wilking N, Carlstrom K, Gustafsson SA, Skoldefors H and Tollbonm O: Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinoma. Eur J Cancer 16: 1339-1344, 1980. (Pubitemid 11232138)
17. Pasqualini JR, Chetrite G and Le Nestour E: Control and expression of estrone sulphatase activities in human breast cancer. J Endoclinol 150: S99-S105, 1996.
18. Evans TRJ, Rowlands MG, Law M and Coombes RC: Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. Br J Cancer 69: 555-561, 1994. (Pubitemid 24076479)
19. Loriaux D, Ruder H and Lipsett M: The mesurement of estrone sulfate in plasma. Steroids 18: 463-472, 1971.
20. Pasqualini J, Gelly C, Nguyen BL and Vella C: Importance of estrogen sulfates in breast cancer. J Steroid Biochem 34: 155-163, 1989. (Pubitemid 20061778)
21. Santner SJ, Wilhelm BO and Santen RJ: Estrogen sulfate promates human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell culture. Int J Cancer 54: 119-124, 1993. (Pubitemid 23137008)
22. James VHT, McNeil JN, Lai LC, Newton CJ, Ghilchik MW and Reed MJ: Aromatase activity in normal breast and breast tumor tissue: in vivo and in vitro studies. Steroids 50: 269-279, 1987.
23. Sasano H, Nagura H, Harada N, Goukon Y and Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535, 1994. (Pubitemid 24173872)
24. Santner SJ, Pauley RJ, Tait L, Kaseta J and Santen RJ: Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metabol 82: 200-208, 1997. (Pubitemid 27021297)
25. Brodie A, Lu Q and Nakamura J: Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 61: 281-286, 1997. (Pubitemid 27455690)
26. Yue W, Zhou D, Chen S and Brodie A: A new nude mouse model for postmenopausal breast cancer using with MCF-7 cells transfected with the human aromatase gene. Cancer Res 54: 5092-5095, 1994. (Pubitemid 24313482)
27. Yue W, Wang J, Savinov A and Brodie A: An effect of aromatase inhibitors on growth of mammary tumors in nude mouse model. Cancer Res 55: 3073-3077, 1995.
28. Ng PC and Osawa Y: Preparation and characterization of the F(ab)2 fragments of an aromatase activity-suppressing monoclonal antibody. Steroids 62: 776-813, 1997.
29. Saeki T, Takashima S, Sasaki H, Hanai N and Salomon DS: Localization of estrone sulfatase in human breast carcinomas. Breast Cancer 6: 331-337, 1999.
30. Toi M, Inada K, Suzuki H and Tominaga T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204, 1995.
31. Inada K, Toi M, Yamamoto Y, Suzuki A, Kurisaki T, Suzuki H and Tominaga T: Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer. Oncol Rep 3: 667-671, 1996. (Pubitemid 26201952)
32. Masamura S, Santner SJ and Santen RJ: Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase. J Steroid Biochem Mol Biol 58: 425-429, 1996. (Pubitemid 26348977)
33. Speirs V, Walton DS, Hall M-C and Atkin SL: In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6. Br J Cancer 81: 690-695 1999. (Pubitemid 29458867)
34. Prost O, Turrel M, Dahan N, Craveur C and Adessi GL: Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma. Cancer Res 44: 661-664, 1984. (Pubitemid 14184601)
35. Gompel A, Somai S, Chaouat M, Kazem A, Kloosterboer HJ, Beusman I, Forgez P, Mimoun M and Rostene W: Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65: 10-11, 2000.
36. Perillo B, Sasso A, Abbondanza C and Palumbo G: 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901, 2000. (Pubitemid 30183508)
37. Santen RJ, Santner SJ, Davis B, Veldhuis J, Samoilik E and Ruby E: Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 47: 1257-1265, 1978. (Pubitemid 9091287)
38. Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G and Brodie A: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137: 3061-3068, 1996. (Pubitemid 26192205)
39. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE and Chen S: Detection of intratumoral aromatase in breast carcinomas: an immunohistochemical study with clinicopathologic correlation. Am J Pathol 140: 337-343, 1992.
40. Santen RJ, Martel J, Hoahland F, Naftolin F, Roa L, Harada N, Hafer L, Zaino R and Santer SJ: Stromal spindle cells contain aromatase in human breast tumours. J Clin Endocrinol Metab 79: 627-632, 1994. (Pubitemid 24256565)
41. Sasano H and Murakami H: Immunolocalization of aromatase in human breast disorders. Breast Cancer Res Treat 49 (Suppl. 1): S79-84, 109-119, 1998.
42. Shenton KC, Dowsett M, Lu Q, Brodie A, Sasano H, Sacks NP and Rowlands MG: Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat 49 (Suppl. 1): S101-107, 109-119, 1998.
43. Santen RJ, Martel J, Hoahland F, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Pauley R and Santer SJ: Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts. Breast Cancer Res Treat 49 (Suppl. 1): S93-99, 109-119, 1998.
44. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG and Nagura H: Aromatase and 17b-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endoclinol Metab 81: 4042-4046, 1996. (Pubitemid 26380415)
45. Toi M, Inada K, Suzuki H, Kondo S and Tominaga T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1: 961-964, 1995.
46. Ferrara N: VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol 11: 617-624, 2000.
47. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I and Coombes RC: Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49: 2588-2591, 1989. (Pubitemid 19143382)
48. Harvey HA: Aromatase inhibitors in breast carcinoma. In: Endocrinology of Breast Cancer. Manni A (ed). Human Press, New Jersey, pp 233-243, 1999.
49. Santen RJ, Worgul T, Lipton A, Harvey H, Boucher A, Samojlik E and Wells SA: Aminoglutethimide as treatment of postmenopausal women with advanced carcinoma. Ann Int Med 96: 94-101, 1982. (Pubitemid 12205528)
50. Dowsett M, Harris AL, Stuart-Hams R, Hill M, Cantwell BMJ, Smith IE and Jefficoate SL: A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. Br J Cancer 52: 525-529, 1985. (Pubitemid 16221573)